A key publication from LSTM reseachers was one of the highest read in the Journal of Immunology this summer.
https://www.jimmunol.org/MostRead
And was highlighted in a recent Nature article: https://www.nature.com/magazine-assets/d41586-019-02753-8/d41586-019-02753-8.pdf
Professor Sara Marshall, Head of Clinical and Physiological Sciences at the Wellcome Trust, who provided funding for this work, said: “This is a fascinating project, and one which could have really far-reaching impact not only for influenza but as a platform technology to develop new medicines for many other diseases that are currently treated by antibodies.”
For more information, please follow the work by Professor Richard J. Pleass's group here: